Trial Profile
The Effects of Crushed Ticagrelor Versus Eptifibatide Bolus +Clopidogrel in Troponin-Negative ACS Patients Undergoing Coronary Intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Eptifibatide (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes; Unstable angina pectoris
- Focus Pharmacodynamics
- 22 Nov 2019 Status changed from recruiting to completed.
- 10 Oct 2016 New trial record